103 related articles for article (PubMed ID: 1550111)
1. Increased expression of natural-killer-associated and activation antigens in multiple myeloma.
Gonzalez M; San Miguel JF; Gascon A; Moro MJ; Hernandez JM; Ortega F; Jimenez R; Guerras L; Romero M; Casanova F
Am J Hematol; 1992 Feb; 39(2):84-9. PubMed ID: 1550111
[TBL] [Abstract][Full Text] [Related]
2. Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
García-Sanz R; González M; Orfão A; Moro MJ; Hernández JM; Borrego D; Carnero M; Casanova F; Bárez A; Jiménez R; Portero JA; San Miguel JF
Br J Haematol; 1996 Apr; 93(1):81-8. PubMed ID: 8611480
[TBL] [Abstract][Full Text] [Related]
3. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).
Van Camp B; Durie BG; Spier C; De Waele M; Van Riet I; Vela E; Frutiger Y; Richter L; Grogan TM
Blood; 1990 Jul; 76(2):377-82. PubMed ID: 1695113
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression.
Richards SJ; Scott CS
Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578
[TBL] [Abstract][Full Text] [Related]
5. Leu-19 in myeloma--a new role for an old antibody.
Wetter O; Brandhorst D; Reiter W
Eur J Cancer; 1990 Apr; 26(4):541. PubMed ID: 1694090
[No Abstract] [Full Text] [Related]
6. Natural killer cell activity in monoclonal gammopathies: relation to disease activity.
Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H
Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786
[TBL] [Abstract][Full Text] [Related]
7. The increase of CD5LOW+NK cells in patients with multiple myeloma and plasmacytoma.
Ishiyama T; Watanabe K; Fukuchi K; Yajima K; Koike M; Tomoyasu S; Tsuruoka N
Anticancer Res; 1994; 14(2B):725-30. PubMed ID: 7516640
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.
Nishikawa K; Saito S; Morii T; Hamada K; Ako H; Narita N; Ichijo M; Kurahayashi M; Sugamura K
Int Immunol; 1991 Aug; 3(8):743-50. PubMed ID: 1716974
[TBL] [Abstract][Full Text] [Related]
9. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
[TBL] [Abstract][Full Text] [Related]
10. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
[TBL] [Abstract][Full Text] [Related]
12. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
[TBL] [Abstract][Full Text] [Related]
13. The clonal hierachy in multiple myeloma.
Rasmussen T; Jensen L; Johnsen HE
Acta Oncol; 2000; 39(7):765-70. PubMed ID: 11145430
[TBL] [Abstract][Full Text] [Related]
14. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
15. The interaction of maintenance interferon with cytolytic cells in patients with multiple myeloma who responded to cytotoxic chemotherapy.
Hall PD; Self SE; Hall RK
Pharmacotherapy; 1997; 17(2):248-55. PubMed ID: 9085315
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.
Funaro A; Spagnoli GC; Ausiello CM; Alessio M; Roggero S; Delia D; Zaccolo M; Malavasi F
J Immunol; 1990 Oct; 145(8):2390-6. PubMed ID: 1976692
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells and CD56+ T cells in the blood of multiple myeloma patients: analysis by 4-colour flow cytometry.
King MA; Radicchi-Mastroianni MA
Cytometry; 1996 Jun; 26(2):121-4. PubMed ID: 8817087
[TBL] [Abstract][Full Text] [Related]
18. [Detection of myeloma cells in the peripheral blood using flow cytometry].
Adam Z; Klabusay M; Vorlícek J; Hájek R
Vnitr Lek; 1997 Sep; 43(9):592-8. PubMed ID: 9750468
[TBL] [Abstract][Full Text] [Related]
19. Large granular lymphocyte proliferation with the natural killer-cell phenotype.
Chan WC; Gu LB; Masih A; Nicholson J; Vogler WR; Yu G; Nasr S
Am J Clin Pathol; 1992 Mar; 97(3):353-8. PubMed ID: 1543158
[TBL] [Abstract][Full Text] [Related]
20. [Myeloma precursor cells].
Iwato K; Kawano MM
Rinsho Ketsueki; 1993 Apr; 34(4):433-8. PubMed ID: 7685432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
